Delta agent (Hepatitis D)Definition: Delta agent is a type of virus called hepatitis D that causes symptoms only in people who have a hepatitis B infection.
Alternative Names: Hepatitis D virus
Causes, incidence, and risk factors: Hepatitis D virus (HDV) is only found in people who carry the hepatitis B virus. HDV may make a hepatitis B infection or existing hepatitis B liver disease worse. It can cause symptoms in people with hepatitis B virus who never had symptoms.
Hepatitis D infects about 15 million people worldwide. It occurs in 5% of people with hepatitis B.
Risk factors include:
- Abusing intravenous (IV) drugs
- Being infected while pregnant (the mother can pass the virus to the baby)
- Carrying the hepatitis B virus
- Having had a hepatitis B infection in the past
- Men having intercourse with other men
- Receiving many blood transfusions
Symptoms: Hepatitis D may make the symptoms of hepatitis B more severe.
Symptoms may include:
- Abdominal pain
- Dark-colored urine
- Fatigue
-
Jaundice
- Joint pain
- Loss of appetite
- Nausea
- Vomiting
Treatment: Many of the medicines used to treat hepatitis B are not helpful for treating hepatitis D. See hepatitis B .
Persons with long-term HDV infection may receive a medicine called alpha interferon for up to 12 months. A liver transplant for end-stage chronic hepatitis B may be effective.
Expectations (prognosis): Persons with an acute HDV infection usually get better over 2 to 3 weeks. Liver enzyme levels return to normal within 16 weeks.
About 10% of those who are infected may develop long-term (chronic) liver inflammation (hepatitis).
Complications:
- Chronic active hepatitis
- Fulminant hepatitis
Calling your health care provider: Call for an appointment with your health care provider if you have symptoms of hepatitis B.
Prevention: Prompt recognition and treatment of hepatitis B infection can help prevent hepatitis D.
Avoid intravenous drug abuse. If you use IV drugs, avoid sharing needles.
A vaccine is available to prevent hepatitis B. It should be considered by people who are at high risk for hepatitis B infection.
References: Dienstag JL. Chronic viral hepatitis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, Pa: Elsevier Churchill Livingstone;2005:chap 112.
| 
